XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
Clinical trial NCT02350686 · UNKNOWN
Trial details
- NCT number
- NCT02350686
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-14
- Primary completion
- 2019-12-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.